Articles from SK Capital

Physical Properties Testers Group Limited (“PPT” or the “Company”), a global leader in physical property test and measurement solutions, announced today the appointment of Mark Fleiner as its new Chief Executive Officer, and Rebecca Henry as its new Chief Financial Officer, both effective January 5, 2026. PPT is a portfolio company of SK Capital.

Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to reduce health care-acquired infections, is pleased to announce the appointment of Ken Miller as Chief Executive Officer and Doug Shook as Chief Commercial Officer. These strategic leadership additions mark a pivotal step in advancing Spectrum’s mission to deliver improved patient outcomes and scale its impact across key markets, building upon recent momentum following a strategic investment by SK Capital in late March.

Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the ingredients, specialty materials, and life sciences sectors, completed the acquisition of Spectra Confectionery Ltd. (“Spectra” or the “Company”) from founders Bill and Maureen Georgas and the Georgas family.

SK Capital, a private investment firm focused on the specialty materials, ingredients and life sciences sectors, completed its previously announced acquisition of the North America Composites & Fuel Containment Division of Parker Hannifin Corporation (NYSE: PH). The business, which has been renamed Axillon Aerospace (“Axillon Aerospace” or the “Company”), is a leading provider of engineered carbon fiber composite components and fuel containment solutions for the defense and commercial aerospace markets. Axillon Aerospace generates annual sales of approximately $350 million, operates six manufacturing locations across the USA and Mexico, and employs approximately 1,700 people.

Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, announced today the signing of an agreement to acquire J&K Ingredients, Inc. (“J&K” or the “Company”). Currently owned by CORE Industrial Partners (“CORE”), J&K is a market leading manufacturer and supplier of food and beverage ingredients with an emphasis on natural, organic, and clean label products. Terms of the deal were not disclosed. The transaction is expected to close before the end of the year.

Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affiliates of SK Capital Partners, LP (“SK Capital”), a leading private investment firm focused on the specialty materials, ingredients, and life sciences sectors. SK Capital has acquired a majority interest in the Company with Mauro Carbone, Ecopol’s CEO and controlling shareholder, retaining a significant stake and remaining as both the CEO and largest individual shareholder. It is also announced the formation of a new Board of Directors, which includes industry leaders with extensive experience across sustainable materials and consumer packaged goods (“CPG”) markets in Ecopol’s value chains, including Jan-Dirk Auris, E. Craig Mitchell, Daniele Ferrari and Dave Mezzanotte.

Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films, announced today the signing of a strategic investment from affiliates of SK Capital Partners, LP (“SK Capital”), a leading private investment firm focused on the specialty materials, ingredients, and life sciences sectors. SK Capital is acquiring a majority interest in the Company with Mauro Carbone, Ecopol’s CEO and controlling shareholder, retaining a significant stake and remaining as both the CEO and largest individual shareholder. Existing minority investor Tikehau Capital, a global alternative asset manager, will also retain a minority stake.

An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced today that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.

Valtris Specialty Chemicals, a leading global manufacturer of a comprehensive portfolio of specialty additives and precursors and a portfolio company of SK Capital, announced today the appointment of Simon Medley as the company’s new Chief Executive Officer, effective September 19, 2022. Mr. Medley will assume the role held formerly by Paul Angus.